Inventor · disambiguated record
Hermes J. Garban
Also filed as: GARBAN HERMES · GARBAN HERMES J · GARBÁN HERMES
6 granted patents·9 pending applications·6 citations·filing 2001–2025
72Inventor score
Top patents by PatentIndex Score
15 records- 0192US11753467B2Anti-TIM3 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2022·Granted Sep 12, 2023·2 cites·20 claims
- 0288US11756651B2Method of treating a tumor in a patient based on an immune gene expressionNANTOMICS LLC·Filed 2018·Granted Sep 12, 2023·4 cites·5 claims
- 0379US12098201B2Anti-TIM3 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2023·Granted Sep 24, 2024·0 cites·19 claims
- 0479US2024336684A1Anti-TIM3 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2024·Application pending·0 cites
- 0578US12412639B2Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samplesNANTOMICS LLC·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
- 0666US2024124598A1Anti-CD30 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2023·Application pending·0 cites
- 0765US11814436B2Anti-CD30 monoclonal antibodies and chimeric antigen receptorsNANTBIO INC·Filed 2022·Granted Nov 14, 2023·0 cites·18 claims
- 0862US12252525B2Chimeric T cell receptors, nucleic acids, and methods of making and using the sameNANTBIO INC·Filed 2021·Granted Mar 18, 2025·0 cites·27 claims
- 0960US2024327492A1Modified T Cell Receptors For The Prevention And Treatment Of Viral Infections And CancerNANTCELL INC·Filed 2022·Application pending·0 cites
- 1058US2022056542A1Rapid Viral Diagnostic TestNANTCELL INC·Filed 2021·Application pending·0 cites
- 1157US2025206800A1Chimeric T Cell Receptors, Nucleic Acids, And Methods Of Making And Using The SameNANTBIO INC·Filed 2025·Application pending·0 cites
- 1252US2021363543A1Self Replicating RNA SystemNANTBIO INC·Filed 2019·Application pending·0 cites
- 1348US2019233900A1Biomarkers in de novo pyrimidine synthesis pathways and chemoresistanceNANTOMICS LLC·Filed 2019·Application pending·0 cites
- 1434US2001038832A1Nitric oxide and analogues thereof effectuate sensitization of neoplasm and immunologically undesired tissues to cytotoxicityFiled 2001·Application pending·0 cites
- 1531US2018112200A1Compositions and methods for generating antigens, antibodies, and immunotherapeutic compositions and methodsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hermes J. Garban files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →